[HTML][HTML] Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
Ischemic heart failure (IHF) is a leading cause of morbidity and mortality worldwide, for
which heart transplantation remains the only definitive treatment. IHF manifests from …
which heart transplantation remains the only definitive treatment. IHF manifests from …
Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
SS Soni, AM D'Elia, CB Rodell - Drug delivery …, 2023 - drexel.esploro.exlibrisgroup.com
Ischemic heart failure (IHF) is a leading cause of morbidity and mortality worldwide, for
which heart transplantation remains the only definitive treatment. IHF manifests from …
which heart transplantation remains the only definitive treatment. IHF manifests from …
Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
SS Soni, AM D'Elia, CB Rodell - Drug delivery and …, 2023 - pubmed.ncbi.nlm.nih.gov
Ischemic heart failure (IHF) is a leading cause of morbidity and mortality worldwide, for
which heart transplantation remains the only definitive treatment. IHF manifests from …
which heart transplantation remains the only definitive treatment. IHF manifests from …
[HTML][HTML] Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
SS Soni, AM D'Elia, CB Rodell - Drug Delivery and Translational …, 2023 - ncbi.nlm.nih.gov
Ischemic heart failure (IHF) is a leading cause of morbidity and mortality worldwide, for
which heart transplantation remains the only definitive treatment. IHF manifests from …
which heart transplantation remains the only definitive treatment. IHF manifests from …
Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches.
SS Soni, AM D'Elia, CB Rodell - Drug Delivery and Translational …, 2023 - europepmc.org
Ischemic heart failure (IHF) is a leading cause of morbidity and mortality worldwide, for
which heart transplantation remains the only definitive treatment. IHF manifests from …
which heart transplantation remains the only definitive treatment. IHF manifests from …
[引用][C] Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
SS Soni, AM D'Elia, CB Rodell - Drug delivery …, 2023 - drexel.esploro.exlibrisgroup.com
Ischemic heart failure (IHF) is a leading cause of morbidity and mortality worldwide, for
which heart transplantation remains the only definitive treatment. IHF manifests from …
which heart transplantation remains the only definitive treatment. IHF manifests from …
Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches.
SS Soni, AM D'Elia, CB Rodell - Drug Delivery and Translational …, 2023 - europepmc.org
Ischemic heart failure (IHF) is a leading cause of morbidity and mortality worldwide, for
which heart transplantation remains the only definitive treatment. IHF manifests from …
which heart transplantation remains the only definitive treatment. IHF manifests from …